Sur1 Inhibitors For Therapy


The full document isn't yet available to us from the patent office.


The present invention provides An NC ca-ATP inhibitor for use in a method for treating and/or preventing: (i) colitis or inflammatory bowel disease in an individual; or (ii) subarachnoid hemorrhage or an inflammation related medical condition that is arthritis, eczema, psoriasis, atopic dermatitis, psoriatic arthropathy, asthma, autoimmune diseases, chronic inflammation, chronic prostatitis, glomerulonephritis, hypersensitivities, pelvic inflammatory disease, reperfusion injury, vasculitis, allergies, shoulder tendinitis, myocarditis, nephritis, bursitis or myopathy in an individual.


Information currently unavailable.

Download Citation

Sign in to the Lens